Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Short term Debt (2020 - 2024)

Historic Short term Debt for Cumberland Pharmaceuticals (CPIX) over the last 5 years, with Q4 2024 value amounting to $5.1 million.

  • Cumberland Pharmaceuticals' Short term Debt changed N/A to $5.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $5.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Short term Debt of $5.1 million as of Q4 2024.
  • In the past 5 years, Cumberland Pharmaceuticals' Short term Debt registered a high of $6.0 million during Q3 2024, and its lowest value of $2.0 million during Q3 2020.